NCT02055560View on ClinicalTrials.gov

Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients

CompletedOBSERVATIONAL
Enrollment

146

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 2, 2015

Study Completion Date

December 18, 2015

Conditions
Metastatic Colorectal CancerAdjuvant Colorectal Cancer5-FU Containing Therapy Regimens
Trial Locations (5)

38555

Tennessee Plateau Oncology, Crossville

60076

Hematology/Oncology of the North Shore, Skokie

75093

Texas Health Physicians Group, Plano

89169

Comprehensive Cancer Centers of Nevada, Las Vegas

92093

University of California San Diego, La Jolla

All Listed Sponsors
lead

Saladax Biomedical, Inc.

INDUSTRY

NCT02055560 - Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients | Biotech Hunter | Biotech Hunter